He graduated from Shanghai Jiao Tong University with a PhD in medicinal chemistry. He has worked in the API R&D departments of Shanghai Record Pharmaceuticals Co., Ltd. , Wuhan Qirui Pharmaceutical and Shanghai Green Valley Pharmaceuticals for 8 years and has nearly 13 years of working experience. He has led his team to complete nearly ten API studies and filings for Class 1, Class 3, Class 5 and Class 6 drugs, and has obtained 4 API manufacturing approvals. As a project leader, he has received funding from the Shanghai Science and Technology Fund, the Hubei Science and Technology Fund and the National 12th Five-Year Plan. He is a founding shareholder of Shanghai Baolong Biotech Co.,Ltd.